对于脏疾病而言,CRISPR和基因编辑:我们在哪里?
Viola D'Ambrosio1, Chen Huimei2, Nicole Vo3
1Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.
Clinical kidney journal
|September 10, 2025
概括
聚类正规间隔短平行体重复 (CRISPR) 基因编辑推进了病研究和治疗. 脏病学中的CRISPR应用范围从了解疾病机制到开发遗传性和多基因性脏疾病的新疗法.
科学领域:
- 生物医学研究生物医学研究
- 腎臟病學 (nephrology) 是一種醫學專業.
- 遗传学 是一个遗传学.
背景情况:
- 基因组编辑技术,特别是CRISPR-Cas9,可以实现精确的基因修改.
- 克里斯普尔是高效,具有成本效益和多功能,从基础研究到潜在疗法都能应用.
- 在病学中,CRISPR对于理解病机制和开发新治疗方法至关重要.
研究的目的:
- 审查基于CRISPR的基因编辑在科的最新进展.
- 突出CRISPR在遗传性脏疾病,多基因脏病和功能基因组学中的应用.
- 讨论CRISPR在病中的治疗潜力和挑战.
主要方法:
- 关于CRISPR在病学中的应用现有文献的综述.
- 使用CRISPR工程器官和动物模型进行的临床前研究分析.
- 检查基于CRISPR的功能屏幕和治疗编辑方法.
主要成果:
- 通过临床前模型,CRISPR提供了对病病理生理学的见解.
- 功能性查确定了糖尿病脏病和淋巴细胞疾病中的新型疾病途径.
- 基础和原始编辑显示了纠正阿尔波特综合征和ADPKD突变的潜力.
结论:
- 基于CRISPR的基因编辑在病研究和治疗方面具有变革性的潜力.
- 在科中,CRISPR促进了药物发现,精准医学和异种移植.
- 临床翻译需要解决诸如交付效率,非目标效应和伦理考虑等挑战.
相关概念视频
CRISPR
57.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.5K
CRISPR/Cas9 Genome Editing
1.7K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.7K
What is Genetic Engineering?
79.7K
Overview
79.7K
CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K
Homologous Recombination
62.7K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.7K
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K


